Neurofibromas are benign, generally painless tumors that can grow on nerves anywhere in the body, including the skull base. In some cases, these soft, fleshy growths develop in the brain, on cranial nerves or on the spinal cord. Multiple neurofibromas are a symptom of neurofibromatosis type 1 (NF1), a genetic disorder formerly known as peripheral NF or von Recklinghausen’s disease.
Johns Hopkins Hospital has earned the top spot in US News News & World Report's annual rankings of American hospitals — for the 21st year in a row. Johns Hopkins Neurology and Neurosurgery is also ranked #1 in the nation.
Chordoma: Drug screening starts to find new treatment for rare bone cancer
The Chordoma Foundation has awarded a $200,000 grant to Dr. Gary Gallia, a skull-base neurosurgeon and cancer biologist at Johns Hopkins. Gallia’s focus is on developing new therapies for brain and skull-based tumors. His lab has a long record of studying mouse models of brain tumors and he has developed a xenograft mouse model to study chordoma.
The Johns Hopkins Comprehensive Brain Tumor Center is a National Cancer Institute (NCI) designated Comprehensive Cancer Center.
The Hunt for a Brain Tumor Vaccine
Connect with Johns Hopkins Medicine
Subscribe to Johns Hopkins Medicine News
Facebook
Twitter
Sharecare
Blogs
YouTube
RSS
Podcasts
